Comparison of four HTLV-I and HTLV-I + II ELISAs

Vox Sanguinis

Volumn 76, Issue 3, 1999, Pages 187-191

  Vrielink, H ^a   Reesink, H W ^a   Habibuw, M R ^a   Schuller, M ^a   Van Der Meer, C B M ^a   Lelie, P N ^a  

^a CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIGEN;

ARTICLE; BLOOD DONOR; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN TISSUE; MAJOR CLINICAL STUDY; PERFORMANCE; PRIORITY JOURNAL; SCREENING TEST;

BLOOD DONORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HTLV-I ANTIGENS; HTLV-II ANTIGENS; HUMANS; MASS SCREENING; SENSITIVITY AND SPECIFICITY;

EID: 0032933497     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000031047     Document Type: Article

References (19)

1. Hjelle B, Mills R, Mertz G, Swenson S: Transmission of HTLV-II via blood transfusion. Vox Sang 1990;59:119-122.
2. Okochi K, Sato H, Hinuma Y: A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion: Seroconversion in recipients. Vox Sang 1994;46:245-253.
3. Centers for Disease Control and Prevention and the USPHS Working Group: Guidelines for counselling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Ann Intern Med 1993;118:448-454.
4. Seiki M, Hattori S, Yoshida M: Human adult T-cell leukemia virus: Molecular cloning of the provirus DNA and the unique terminal structure. Proc Natl Acad Sci USA 1982;79:6899-6902.
5. Manns A, Blattner WA: The epidemiology of the human T-cell lymphotropic virus type I and type II: Etiologic role in human disease. Transfusion 1991;31:67-75.
6. Gout O, Baulac M, Gessain A, Semah F, Saal F, Peries J. Cabrol C, Foucault-Fretz C, Laplane D, Sigaux F, de The G: Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990;322:383-388.
7. Anderson DW, Epstein JS, Lairmore MD, Lee TH, Lairmore MD, Saxinger C, Kalyanaraman VS, Slamon D, Parks W, Poiesz LT, Lee H, Montanaga R, Williams A, Blattner W: Serological confirmation of human T-cell lymphotropic virus type I infection in healthy blood and plasma donors. Blood 1989;74: 2585-2591.
8. Kira J-I, Koyanagi Y, Hamakado T, Itoyama Y, Yamamoto N, Goto I: HTLV-II in patients with HTLV-I associated myelopathy. Lancet 1991; 338:64-65.
9. Hjelle B, Appenzeller O, Mills R, Alexander S, Torrez-Martinez N, Jahnke R, Ross G: Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992;339:645-646.
10. Murphy EL, Engstom JW, Miller K, Sacher RA, Busch MP, Hollingsworth CG: HTLV-II associated myelopathy in 43-year-old woman. Lancet 1993;341:757-758.
11. Finney DJ: Probit Analysis. Cambridge, Cambridge University Press, 1971.
12. Vrielink H, Reesink HW: Analysis of the sensitivity of reagents by testing panels of dilutions of positive sera versus panels of weak-positive native sera (abstract). Transfusion 1997;37(suppl):S103.
13. Shimotohno K, Takahashi Y, Shimizu N, Gojobori T, Golde DW, Chen IS, Miwa M. Sugimura T: Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: An open reading frame for the protease gene. Proc Natl Acad Sci USA 1985;82:3101-3105.
14. Wiktor SZ, Pate EJ, Weiss SH, Gohd RS, Correa P, Fontham ET, Hanchard B, Biggar RJ, Blattner WA: Sensitivity of HTLV-I antibody assays for HTLV-II. Lancet 1991;338:512-513.
15. Hjelle B, Wilson C. Cyrus S, Bradshaw P, Lo J, Scammel C, Wiltbank T, Alexander S: Human T-cell leukemia virus type II infection frequently goes undetected in contemporary US blood donors. Blood 1993;81:1641-1644.
16. Rios M, Khabbaz RF, Kaplan JE, Hall WW, Kessler D, Bianco C: Transmission of human T-cell lymphotropic virus (HTLV) type II by transfusion of HTLV-I screened blood products. J Infect Dis 1994;170:206-210.
17. North ML, Lemaire JM, Couroucé JAM, and the SFTS Retrovirus Group: Performance of kits for the detection of anti-HTLV-I/II anti-bodies commercialized in France in 1995. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:254.
18. Vrielink H, Reesink HW, Zaaijer HL, van der Poel CL, Cuypers HTM, Lelie PN: Sensitivity and specificity of four anti-humun T-cell lymphotropic virus type I or type I/II assays. Transfusion 1996;36:344-347.
19. The HTLV European Research Network: Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europa. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:68-77.